- Home
- TARA vs CBFV Comparison
TARA vs CBFV Comparison
Compare TARA & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- CBFV
- Stock Information
- Founded
- TARA N/A
- CBFV 1901
- Country
- TARA United States
- CBFV United States
- Employees
- TARA N/A
- CBFV N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- CBFV Major Banks
- Sector
- TARA Health Care
- CBFV Finance
- Exchange
- TARA Nasdaq
- CBFV Nasdaq
- Market Cap
- TARA 126.5M
- CBFV 140.0M
- IPO Year
- TARA N/A
- CBFV N/A
- Fundamental
- Price
- TARA $2.86
- CBFV $28.69
- Analyst Decision
- TARA Strong Buy
- CBFV Hold
- Analyst Count
- TARA 7
- CBFV 2
- Target Price
- TARA $20.67
- CBFV $26.00
- AVG Volume (30 Days)
- TARA 452.7K
- CBFV 43.0K
- Earning Date
- TARA 08-05-2025
- CBFV 07-23-2025
- Dividend Yield
- TARA N/A
- CBFV 3.57%
- EPS Growth
- TARA N/A
- CBFV N/A
- EPS
- TARA N/A
- CBFV 1.92
- Revenue
- TARA N/A
- CBFV $49,545,000.00
- Revenue This Year
- TARA N/A
- CBFV $5.97
- Revenue Next Year
- TARA N/A
- CBFV $9.49
- P/E Ratio
- TARA N/A
- CBFV $14.63
- Revenue Growth
- TARA N/A
- CBFV N/A
- 52 Week Low
- TARA $1.60
- CBFV $20.99
- 52 Week High
- TARA $10.48
- CBFV $33.72
- Technical
- Relative Strength Index (RSI)
- TARA 43.02
- CBFV 37.26
- Support Level
- TARA $3.12
- CBFV $27.11
- Resistance Level
- TARA $3.10
- CBFV $27.76
- Average True Range (ATR)
- TARA 0.19
- CBFV 0.35
- MACD
- TARA -0.01
- CBFV -0.07
- Stochastic Oscillator
- TARA 17.19
- CBFV 32.20
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.